Certainly! Here is the content from the provided web search results:
AI Ethics in Journalism (Studies): An Evolving field Between Research and practice
Grounded in the review of existing research and analytical reasoning,we first discuss how news organizations have (slowly) approached ethical concerns related to AI technology,developing a critical stance over time,in particular because the “tension between the industry and profession of journalism in highlighting the hopes and pitfalls of AI” (Moran & Shaikh,2022,p. 1756) became more …
URL: https://journals.sagepub.com/doi/10.1177/27523543241288818
A data-centric approach for ethical and trustworthy AI in journalism
AI-driven journalism refers to various methods and tools for gathering, verifying, producing, and distributing news facts. Their potential is to extend human capabilities and create new forms of augmented journalism.Even though scholars agreed on the necessity to embed journalistic values in these systems to make AI systems accountable, less attention was paid to data quality, while the…URL: https://link.springer.com/article/10.1007/s10676-024-09801-6
digital newsroom Change: A Systematic Review of the …
Artificial Intelligence (AI) fundamentally changes journalism, yet a extensive understanding of its impact is limited. This study presents the first systematic review to thoroughly analyze the influence of AI on journalism. …URL: https://www.mdpi.com/2076-3417/12/7/3512
These are the contents from the provided web search results.China Defends Generic Drugs Amid quality Concerns
SHANGHAI – China’s healthcare regulator has come forward to defend the efficacy of off-patent medicines distributed through public hospitals. The National Healthcare Security Management (NHSA) addressed quality concerns, asserting that an examination found these claims to be unsubstant.
In an interview with the state-backed People’s Daily newspaper, the NHSA explained that rigorous evaluations ensure generic drugs match the quality and efficacy of original research drugs. Post-approval, these drugs are strictly supervised to maintain standards.
Last month, the NHSA initiated an investigation into these concerns. They consulted experts and hospital heads to determine the validity of the claims. The regulator concluded that perceptions of reduced effectiveness in generic drugs, such as anaesthetics and laxatives, stemmed from “subjective feelings.”
China introduced the bulk-buy program in 2018 to negotiate lower prices from drug manufacturers.This programme has since expanded across the country. The drugs on the list include off-patent blockbusters from Western pharmaceutical giants and generics produced by local players.
While the scheme pressures margins, many drugmakers participate in tenders to supply public hospitals in large volumes. This approach helps in maintaining affordability and accessibility of essential medicines.
For more details, visit People’s Daily.
